Michael Truett Tate, Chief Financial Officer at Astera Labs, Inc. (ALAB), sold 30,100 shares at $117.68 ($3.5M) on 2024-12-04, disclosed to the SEC on 2024-12-06.
Scheduled sale ($3.5M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $115.44 | 3,622 | $418K | 11.8% |
| 2 | $115.44 | 3,622 | $418K | 11.8% |
| 3 | $116.66 | 1,900 | $222K | 6.2% |
| 4 | $117.68 | 2,840 | $334K | 9.4% |
| 5 | $117.68 | 2,840 | $334K | 9.4% |
| 6 | $118.44 | 2,602 |
| $308K |
| 8.7% |
| 7 | $118.44 | 2,602 | $308K | 8.7% |
| 8 | $119.67 | 4,353 | $521K | 14.7% |
| 9 | $119.67 | 4,353 | $521K | 14.7% |
| 10 | $120.58 | 683 | $82K | 2.3% |
| 11 | $120.58 | 683 | $82K | 2.3% |
| Total | $117.92 avg | 30,100 | $3.5M | 100% |
| Filing → |
| ALAB | SELL | 2025-08-20 | $6.9M | — | Filing → |
| ALAB | SELL | 2025-08-20 | $33.0M | — | Filing → |
| ALAB | SELL | 2025-08-14 | $38.2M | — | Filing → |